{"id":"https://openalex.org/W2184824360","doi":"https://doi.org/10.1002/jlb.39.3.313","title":"Decreased Expression of Class II Major Histocompatibility Antigens on Monocytes From Patients With Hodgkin's Disease","display_name":"Decreased Expression of Class II Major Histocompatibility Antigens on Monocytes From Patients With Hodgkin's Disease","publication_year":1986,"publication_date":"1986-03-01","ids":{"openalex":"https://openalex.org/W2184824360","doi":"https://doi.org/10.1002/jlb.39.3.313","mag":"2184824360","pmid":"https://pubmed.ncbi.nlm.nih.gov/3484776"},"language":"en","primary_location":{"id":"doi:10.1002/jlb.39.3.313","doi":"https://doi.org/10.1002/jlb.39.3.313","is_oa":false,"landing_page_url":"https://doi.org/10.1002/jlb.39.3.313","pdf_url":null,"source":{"id":"https://openalex.org/S199011235","display_name":"Journal of Leukocyte Biology","issn_l":"0741-5400","issn":["0741-5400","1938-3673"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Leukocyte Biology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5112139223","display_name":"Hiroko Nagai","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405285868","display_name":"Brain Research Institute, Niigata University","ror":"https://ror.org/00hy9c257","country_code":"JP","type":"facility","lineage":["https://openalex.org/I4405285868","https://openalex.org/I71395657"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hiroko Nagai","raw_affiliation_strings":["Department of Neurology, Brain Research Institute, Niigata University of Medicine , Niigata, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology, Brain Research Institute, Niigata University of Medicine , Niigata, Japan","institution_ids":["https://openalex.org/I4405285868"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111441938","display_name":"Richard I. Fisher","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Richard I Fisher","raw_affiliation_strings":["The Medicine Branch, Clinical Oncology Program, Division of Cancer Treatment , Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Medicine Branch, Clinical Oncology Program, Division of Cancer Treatment , Maryland","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056389427","display_name":"Jeffrey Cossman","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jeffrey Cossman","raw_affiliation_strings":["The Hematopathology Section, Laboratory of Pathology, Division of Cancer Biology and Diagnosis , Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Hematopathology Section, Laboratory of Pathology, Division of Cancer Biology and Diagnosis , Maryland","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5042240287","display_name":"Joost J. Oppenheim","orcid":"https://orcid.org/0000-0003-0271-7921","observed_orcids":["https://orcid.org/0000-0003-0271-7921"]},"institutions":[{"id":"https://openalex.org/I4210130649","display_name":"Frederick National Laboratory for Cancer Research","ror":"https://ror.org/03v6m3209","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210130649","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Joost J Oppenheim","raw_affiliation_strings":["The Laboratory of Molecular Immunoregulation, Biological Response Modifiers Program, Division of Cancer Treatment, Frederick Cancer Research Facility, National Cancer Institute , Frederick, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Laboratory of Molecular Immunoregulation, Biological Response Modifiers Program, Division of Cancer Treatment, Frederick Cancer Research Facility, National Cancer Institute , Frederick, Maryland","institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4210140884"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5042240287","https://openalex.org/A5111441938"],"corresponding_institution_ids":["https://openalex.org/I4210130649","https://openalex.org/I4210140884"],"apc_list":{"value":3800,"currency":"USD","value_usd":3800},"apc_paid":null,"fwci":1.7609,"has_fulltext":false,"cited_by_count":15,"citation_normalized_percentile":{"value":0.85383002,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"39","issue":"3","first_page":"313","last_page":"321"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9179999828338623,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9179999828338623,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.022700000554323196,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11313","display_name":"Immune cells in cancer","score":0.004600000102072954,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hodgkin-lymphoma","display_name":"Hodgkin's disease","score":0.996999979019165},{"id":"https://openalex.org/keywords/monocytes","display_name":"monocytes","score":0.7979999780654907},{"id":"https://openalex.org/keywords/hla-dr","display_name":"HLA-DR","score":0.9589999914169312},{"id":"https://openalex.org/keywords/indomethacin","display_name":"indomethacin","score":0.7990000247955322},{"id":"https://openalex.org/keywords/prostaglandin-e","display_name":"prostaglandin E","score":0.8579999804496765},{"id":"https://openalex.org/keywords/interleukin-1","display_name":"interleukin-1","score":0.8529999852180481},{"id":"https://openalex.org/keywords/interferon-gamma","display_name":"interferon-gamma","score":0.8730000257492065},{"id":"https://openalex.org/keywords/concanavalin-a","display_name":"concanavalin A","score":0.800000011920929},{"id":"https://openalex.org/keywords/disease-stage","display_name":"disease stage","score":0.8190000057220459}],"concepts":[{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.8783712387084961},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.6101742386817932},{"id":"https://openalex.org/C202965653","wikidata":"https://www.wikidata.org/wiki/Q2664028","display_name":"Histocompatibility","level":4,"score":0.6066850423812866},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.5939117670059204},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.5692781805992126},{"id":"https://openalex.org/C207936829","wikidata":"https://www.wikidata.org/wiki/Q423163","display_name":"Major histocompatibility complex","level":3,"score":0.5655876994132996},{"id":"https://openalex.org/C48556533","wikidata":"https://www.wikidata.org/wiki/Q6869184","display_name":"Minor histocompatibility antigen","level":4,"score":0.5234895944595337},{"id":"https://openalex.org/C2777212361","wikidata":"https://www.wikidata.org/wiki/Q5127848","display_name":"Class (philosophy)","level":2,"score":0.44249439239501953},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.3337523639202118},{"id":"https://openalex.org/C188280979","wikidata":"https://www.wikidata.org/wiki/Q911125","display_name":"Human leukocyte antigen","level":3,"score":0.28049761056900024},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.11794880032539368},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.0},{"id":"https://openalex.org/C154945302","wikidata":"https://www.wikidata.org/wiki/Q11660","display_name":"Artificial intelligence","level":1,"score":0.0},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000949","descriptor_name":"Histocompatibility Antigens Class II","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":true},{"descriptor_ui":"D003208","descriptor_name":"Concanavalin A","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006684","descriptor_name":"HLA-DR Antigens","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006689","descriptor_name":"Hodgkin Disease","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007213","descriptor_name":"Indomethacin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D007375","descriptor_name":"Interleukin-1","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D007958","descriptor_name":"Leukocyte Count","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009000","descriptor_name":"Monocytes","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D011458","descriptor_name":"Prostaglandins E","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1002/jlb.39.3.313","doi":"https://doi.org/10.1002/jlb.39.3.313","is_oa":false,"landing_page_url":"https://doi.org/10.1002/jlb.39.3.313","pdf_url":null,"source":{"id":"https://openalex.org/S199011235","display_name":"Journal of Leukocyte Biology","issn_l":"0741-5400","issn":["0741-5400","1938-3673"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Leukocyte Biology","raw_type":"journal-article"},{"id":"pmid:3484776","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/3484776","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of leukocyte biology","raw_type":"Journal Article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.482.4050","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.482.4050","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://www.jleukbio.org/content/39/3/313.full.pdf","raw_type":"text"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":20,"referenced_works":["https://openalex.org/W13805137","https://openalex.org/W216282036","https://openalex.org/W1493327257","https://openalex.org/W1500836458","https://openalex.org/W1522812742","https://openalex.org/W1589480977","https://openalex.org/W1603914738","https://openalex.org/W1911120442","https://openalex.org/W1981684603","https://openalex.org/W2052948151","https://openalex.org/W2061983161","https://openalex.org/W2065564934","https://openalex.org/W2083276447","https://openalex.org/W2091519877","https://openalex.org/W2145080356","https://openalex.org/W2321158747","https://openalex.org/W2398801144","https://openalex.org/W2406417247","https://openalex.org/W2414279893","https://openalex.org/W2427041443"],"related_works":["https://openalex.org/W7099036014","https://openalex.org/W2295630215","https://openalex.org/W2410656793","https://openalex.org/W786164274","https://openalex.org/W2406231793","https://openalex.org/W1991337645","https://openalex.org/W1994167292","https://openalex.org/W1538703617","https://openalex.org/W2008916824","https://openalex.org/W2183455325"],"abstract_inverted_index":{"Expression":[0],"of":[1,29,76,80,87,247],"class":[2,30,176],"II":[3,31,125,177,235],"major":[4],"histocompatibility":[5],"(MHC)":[6],"antigens":[7,33],"by":[8,101,135,209,216],"peripheral":[9],"blood":[10],"monocytes":[11,39,131,153,183,218],"from":[12],"12":[13],"patients":[14,61,72],"with":[15,62,73,156],"Hodgkin's":[16,122,254],"disease":[17,77],"(HD)":[18],"were":[19,132,154],"studied":[20],"employing":[21],"antiserum":[22],"and":[23,105,160,168,226],"complement-mediated":[24],"cytotoxicity.":[25],"Overall,":[26],"the":[27,205,232,248],"expression":[28,70,128,163,180,208,241],"MHC":[32,126,178,234],"was":[34,57,78,96,109,164,219],"significantly":[35],"decreased":[36,206,233],"on":[37,129,181],"HD":[38,130,167,182,210],"(cytotoxicity":[40],"index":[41],"[C.I.]":[42],"=":[43,185],"60.2":[44],"+/-":[45,49,187,191],"5.8%":[46],"vs":[47,189],"77.6":[48],"2.8%,":[50],"P":[51,193],"less":[52,194],"than":[53,118,195],".02).":[54],"This":[55],"decrease":[56],"most":[58],"marked":[59],"in":[60,83,115,119,166,239,253],"more":[63,111],"severe":[64],"disease.":[65,255],"In":[66],"fact,":[67],"mean":[68],"alloantigen":[69,162,207,240],"for":[71,204],"advanced":[74,121],"stages":[75],"58%":[79],"that":[81,199],"observed":[82],"controls.":[84],"The":[85],"number":[86],"human":[88,141],"lymphocyte":[89],"antigen":[90,127,179,236],"(HLA)-DR":[91],"antigenic":[92],"sites":[93],"per":[94,113],"cell":[95,114,143],"also":[97],"reduced":[98,221],"as":[99,222],"determined":[100],"monoclonal":[102],"anti-DR":[103],"antibody":[104],"FACS":[106],"analysis.":[107],"There":[108],"38%":[110],"HLA-DR":[112],"normal":[116],"controls":[117],"moderately":[120],"patients.":[123],"Class":[124],"increased":[133,165],"partially":[134],"an":[136,244],"IFN-gamma":[137],"containing":[138],"concanavalin":[139],"A-stimulated":[140],"mononuclear":[142],"culture":[144],"supernatants":[145],"(Con":[146],"A":[147,158],"sup),":[148],"although":[149],"remaining":[150],"subnormal.":[151],"When":[152],"cultured":[155],"Con":[157],"sup":[159],"indomethacin,":[161],"control":[169],"monocytes,":[170],"but":[171],"indomethacin":[172],"failed":[173],"to":[174,224,231],"normalize":[175],"(C.I.":[184],"72.3":[186],"4.7%":[188],"90.2":[190],"1.8%,":[192],".01).":[196],"We":[197],"conclude":[198],"PGE":[200],"accounts":[201],"only":[202],"inpart":[203],"monocytes.":[211],"Interleukin":[212],"(IL)":[213],"1":[214],"production":[215],"patients'":[217],"not":[220,229],"compared":[223],"normals":[225],"therefore":[227],"does":[228],"contribute":[230],"expression.":[237],"Decreases":[238],"may":[242],"be":[243],"important":[245],"determinant":[246],"T":[249],"cell-mediated":[250],"immune":[251],"abnormalities":[252]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}